In conclusion, our results demonstrated that NM23 expression was associated with the progression of NSCLC, which is consistent with the report of You et al.[66] Therefore, NM23 expression can be used as a reliable and independent prognostic indicator of NSCLC. The gene discussed is NME1; the disease is non-small cell lung carcinoma.